Acadia Pharmaceuticals amends bylaws, tightens stockholder nomination and meeting rules

ACADIA PHARMACEUTICALS INC

Quorum threshold changed from majority of outstanding shares to majority of voting power.
Stockholder nominees limited to number of directors to be elected; substitute nominees prohibited.
Advance notice window widened: alternative window applies if annual meeting delayed >70 days (was 30).
Mandatory indemnification and expense advancement for directors/officers expanded to maximum extent allowed.
Exclusive forum provisions clarified, including U.S. federal district courts for Securities Act claims.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.